IMPORTANCE Improving emergency care of pediatric sepsis is a public health priority, but optimal early diagnostic approaches are unclear. Measurement of lactate levels is associated with improved outcomes in adult septic shock, but pediatric guidelines do not endorse its use, in part because the association between early lactate levels and mortality is unknown in pediatric sepsis.
dren has been attributed to failures of early recognition.
3,4 Public concern about preventable mortality due to sepsis has led to state laws for pediatric sepsis care, and the American Academy of Pediatrics and Children's Hospital Association have launched national pediatric sepsis quality improvement programs. [5] [6] [7] Difficulty in standardizing meaningful clinical definitions and diagnostic techniques for pediatric sepsis are challenges in these initiatives. Measurement of venous lactate levels has been effective in emergency care of adults with sepsis and is a pay-forperformance metric in adult sepsis reported to the Centers for Medicare & Medicaid Services, and an elevated lactate level is part of the definition of adult septic shock. [8] [9] [10] Serum lactate levels rise in sepsis through multiple mechanisms, including anaerobic metabolism from tissue hypoperfusion, decreased clearance, and a bioenergetic response to sepsis favoring lactate production. 11, 12 A venous lactate level of greater than 36 mg/dL (to convert to millimoles per liter, multiply by 0.111) is associated with increased mortality in adults with sepsis, but implementation of lactate testing has been associated with improved outcome in adults. 8, 13, 14 Measurement of lactate levels is useful for prognostication and for monitoring success of resuscitative efforts; more than a biomarker, its rapid changes during early treatment of pediatric sepsis are dynamically prognostic. 15 Evidence about the utility of early lactate measurement in pediatric sepsis is limited, and its use is not endorsed in pediatric sepsis guidelines. 16 The main objective of this study was to determine whether the initial venous lactate level in the emergency care of suspected sepsis in children is associated with 30-day mortality. Our hypothesis was that an initial serum lactate level greater than 36 mg/dL would be associated with increased mortality compared with levels of 36 mg/dL or less. In a secondary analysis, we also assessed clinical outcomes in patients grouped by lactate level.
Methods

Study Design
This observational cohort study used a clinical sepsis registry created to support clinical quality improvement work. The registry was approved by the Children's Hospital Colorado Organizational Research Risk and Quality Improvement Review Panel. Extraction of data from the registry into a deidentified data set for generalizable research was approved by the Colorado Multiple institution review board, who waived the need for informed consent for this study.
Setting
This study was conducted at a tertiary free-standing pediatric hospital with more than 75 000 yearly emergency department (ED) visits. Institutional ED protocols include an activation process for suspected sepsis consisting of protocolized mobilization of additional personnel and equipment and order sets and standardized procedures for the rapid initiation of intravenous access, fluid resuscitation, antibiotic administration, and critical therapeutics. Lactate testing is recommended but clinicians may override the default order at their discretion.
Data Source
The Colorado Sepsis Treatment and Recognition Registry was derived from electronic health record (EHR) data recorded clinically during routine patient care, including vital signs, treatments delivered, timing of patient care events, and laboratory results. The registry contains variables identified by the clinical quality improvement team as relevant to the emergency care of pediatric sepsis. The sepsis registry is populated with patients in the ED identified through the presence of any of the following in the EHR: (1) use of a sepsis-specific order set in the ED; (2) use of the sepsis activation system in the ED; and (3) missed ED cases. Personnel in the ED are trained to identify cases of suspected sepsis following American College of Critical Care Medicine guidelines for clinical recognition of septic shock, which recommend treatment for patients demonstrating "decreased mental status or perfusion" in the setting of suspected infection. 16(p677) Although sepsis activation is recommended for clinically suspected sepsis, when the recommendation is not followed, components of sepsis care may be delivered without an activation. Missed cases were identified in the following manner: (1) all patients placed in intensive care within 24 hours of ED care who received antibiotics or were hypotensive were identified through automated monthly EHR query as possible missed cases; (2) 2 trained reviewers (including H.F.S.) reviewed these possible missed cases monthly to determine whether the cases had clinical sepsis in the ED (decreased mental status or perfusion in the setting of suspected infection); and (3) cases of sepsis identified through missed patient review were included in the database. Missed cases were initially independently reviewed by a pediatric emergency nurse and pediatric emergency physician, who were blinded to each other's assessment, and differences were reconciled. This process continued for 3 months, after which time monthly assessment of interrater reliability between reviewers demonstrated a κ value of greater than 0.8 for classification of cases as missed sepsis. Subsequently each case was reviewed by one of the 2 reviewers, with ongoing yearly audits of 10% of records continuing to demonstrate a κ value of greater than 0.8.
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Key Points
Question Is an initial venous lactate level of greater than 36 mg/dL associated with 30-day in-hospital mortality in children with clinically suspected sepsis?
Findings In this observational cohort study of 1299 children included in a pediatric emergency department sepsis registry, an initial lactate level of greater than 36 mg/dL was associated with 30-day mortality. Lactate levels had a sensitivity of 20% and specificity of 92% for mortality.
Meaning Lactate levels do not represent an optimal stand-alone screening test but may have utility as a prognostic tool in the emergency care of clinically suspected sepsis in children.
loads updated time-dependent fields that were incomplete at the original load, such as hospital length of stay or 30-day mortality. Routine quality auditing identified specific variables as unreliably captured in the EHR; these underwent medical record review and manual data entry monthly, including the fewer than 1% of encounters that included paper (non-EHR) resuscitation records. A deidentified Health Insurance Portability and Accountability Act-compliant data set was exported from REDCap into SAS (version 9.4; SAS Institute Inc) for analysis.
Cohort
All patients in the Colorado Sepsis Treatment and Recognition Registry during the first 45 months of operation (April 1, 2012, to December 31, 2015) were included. Patients were excluded if they were younger than 60 days or 18 years or older, were transferred from another medical facility, or had not undergone measurement of a venous lactate level during the first 8 hours after ED arrival. Only measurement of venous lactate levels qualified a patient for inclusion.
Outcomes
The primary outcome was in-hospital, all-cause mortality within 30 days after initial ED arrival, as recorded in the EHR. Additional clinical outcomes that were prespecified included intensive care unit (ICU) admission, endotracheal intubation, use of vasoactive agents, hospital length of stay longer than 3 days, ICU length of stay longer than 2 days, ventilator days, and days of treatment with a vasoactive agent.
Exposure
An initial venous lactate level greater than 36 mg/dL was the primary exposure. Only patients with a venous lactate level measured during the first 8 hours after ED arrival were included, and only the first lactate level measured was considered. This level was chosen based on adult data identifying a lactate level greater than 36 mg/dL as a risk factor for mortality. 13, 19 In a secondary analysis, lactate levels were grouped as low (<18 mg/dL), intermediate (18-36 mg/dL), and high (>36 mg/dL) and considered as relevant variables, also based on adult literature establishing these cut points as relevant.
10,13
Lactate levels were measured following the clinical standards of the Children's Hospital Colorado certified laboratory. During the study period, approved devices used to measure lactate level were the Rapidlab 1265 (Siemens Healthcare Diagnostics Inc) and the i-STAT (Abbott Laboratories).
Covariates and Missing Data
Covariates were identified a priori based on the medical literature, including variables from risk scores in adult sepsis and pediatric infectious disease. 20, 21 Children with complex chronic conditions were identified following published criteria using codes from the International Classification of Diseases, Ninth Revision, and International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, in the EHR problem lists. 22 To evaluate the role of bowel ischemia, deaths and operative cases were reviewed to determine whether a presumed abdominal source of sepsis existed, and an abdominal source was considered for inclusion as a covariate in the multivariable analysis. In assessing organ dysfunction, when laboratory values were missing because the clinical team chose not to order the test, levels were considered within a reference range, a standard approach in clinical risk modeling that reflects clinical bedside decision making. 23 
Statistical Analysis
Data were analyzed using SAS software (version 9.4; SAS Institute Inc). Standard descriptive statistics were reported with median and interquartile range for continuous variables and frequency and percentage for categorical variables. To determine the association between lactate levels and 30-day mortality, an adjusted odds ratio (OR) was calculated using logistic regression to account for potential confounders. The effect of including each potential covariate in a logistic regression model was calculated one at a time. Those covariates influencing the OR by more than 10% were then included in multivariable logistic regression models, and backward elimination was used to identify models that were compared using model-fitting statistics, including the Hosmer-Lemeshow goodness-of-fit test.
Because the goal of the study was to examine lactate level as associated with risk, only characteristics of the patient and initial clinical presentation were considered as covariates. The effects of treatment delivered after lactate levels were measured were explored by calculating associations between lactate level and mortality with each treatment covariate added in logistic regression.
Differences in clinical outcomes among 3 lactate level groups were tested using the Mantel-Haenszel test. A subanalysis including only patients with lactate levels measured less than 2 hours after sepsis recognition was conducted to remove the potential influence of delays in care.
Results
Participant Characteristics
From April 1, 2012, through December 31, 2015, 2520 patients underwent evaluation for sepsis; 1700 (67.5%) underwent measurement of lactate levels; an additional 401 patients were excluded for age or transfer status. Figure 1 , and patient characteristics and ED care in Table 1 and Table 2 and eTable 1 in the Supplement. Eight hundred ninety-nine patients (69.2%) had chronic medical conditions and 367 (28.3%) had acute organ dysfunction. The median lactate level was 14.4 (95% CI, 9.9-21.6) mg/dL. Lactate level was measured a median of 24.0 (95% CI, 9.0-49.0) minutes after arrival in survivors and 21.0 (95% CI, 15.0-39.0) minutes in nonsurvivors and before initiation of therapy with vasoactive agents and fluid resuscitation in all cases. Twentyfive patients (1.9%) experienced 30-day mortality.
Five patients had an operative abdominal source of sepsis; none died. The lactate level was elevated in 1 patient. Given
Association Between Lactate Level and Mortality
Mortality rates were higher in patients with initial lactate levels greater than 36 mg/dL (5 of 103 patients [4.8%] vs 20 of 1196 patients [1.7%]) (Figure 2) . Initial lactate levels greater than 36 mg/dL were significantly associated with 30-day mortality in unadjusted (OR, 3.00; 95% CI 1.10-8.17) and adjusted (adjusted OR, 3.26; 95% CI, 1.16-9.16) analyses. The effect of including an individual covariate in a logistic regression model of the relationship between elevated lactate and 30-day mortality is shown in eTable 2 in the Supplement. Hypotension (OR, 2.28; 95% CI, 1.03-7.75; −24% change in OR from base model; P = .04) and chronic complex condition (OR, 3.69; 95% CI, 1.33-10.26; 23% change in OR from base model; P = .01) in the ED were significant covariates included in the final model, which demonstrated goodness-of-fit with P = .58 for the Hosmer-Lemeshow test. Excluding laboratory tests that were not ordered by the treating clinicians with results that were considered within reference ranges, data were otherwise missing in 0 to 0.8% of individual variables assessed for inclusion in the model. The effects of treatment delivered on the association between lactate levels and mortality are shown in eTable 3 in the Supplement.
Sensitivity of a lactate level greater than 36 mg/dL for 30-day mortality was 20.0% (95% CI, 8.9%-39.1%), and specificity was 92.3% (95% CI, 90.7%-93.7%). The positive likelihood ratio was 2.60 (95% CI, 1.16-5.83). Among patients with low, intermediate, and high lactate levels, larger proportions of patients had secondary clinical utilization outcomes as the lactate level group increased (Figure 3) .
Patients With Lactate Levels Measured Late or Unmeasured
Eight hundred twenty patients with unmeasured lactate levels were excluded from the cohort (eTable 4 in the Supplement). The unadjusted OR of 30-day mortality in patients with unmeasured lactate levels was 0.31 (95% CI, 0.12-0.82). In a subanalysis excluding patients with lactate levels measured more than 120 minutes after sepsis recognition, 21 patients were excluded and the OR of mortality for the remaining patients with lactate levels greater than 36 mg/dL was 3.14 (95% CI, 1.15-8.59).
Discussion
Early sepsis in children may be difficult to recognize. Underestimation of disease severity and underresuscitation across the continuum from the community setting to the ED and in-hospital care has been identified as a major contributor to pediatric death due to infection.
3,4 Diagnostic and prognostic questions remain central even in tertiary pediatric centers, where studies identify delays in shock recognition as a barrier to effective care. 24 The success of lactate level measurement in adult strategies for diagnosis and prognostication in septic shock has been compelling to pediatricians. Although formal guidelines have not endorsed measurement of lactate levels owing to insufficient evidence, it has been a component of successful pediatric emergency sepsis quality programs within the last 5 years and is used in emergency care of pediatric sepsis by 68% of pediatric emergency physicians responding to a recent survey.
24-27
The finding of this study that early lactate levels in the ED are associated with mortality due to suspected sepsis in children, although new, is consistent with findings of other studies of lactate levels in pediatric sepsis. Lactate levels have been associated with mortality in the pediatric ICU. 28, 29 Unlike ICU-based stud-
ies, the present study tested lactate levels before receipt of therapy and was not subject to potential bias from medications such as exogenous epinephrine, which directly causes elevation of lactate levels. Early lactate levels have previously been associated with organ dysfunction and prolonged length of hospital stay in pediatric sepsis. 30, 31 To our knowledge, lactate levels had not previously been tested for an association with mortality in an ED cohort where mortality due to pediatric sepsis is substantially lower than in the ICU. This study of lactate levels early in ED care is important because the first hours of sepsis care are critical to the outcome. Lactate levels were measured a mean of less than 30 minutes after ED arrival, when the procedure may be most useful. This study found that lactate levels are a low-sensitivity and high-specificity test for mortality. Lactate levels alone would thus not be an effective screening test for the rare and temporally distant event of mortality. Although lactate levels were associated with an increased risk for mortality, most patients in the study with elevated lactate levels survived. Rather than as a screening test, lactate levels might best be used to identify the highest-risk patients among those in whom the treating clinician has already identified a potential clinical concern for sepsis. This study does not suggest a causal association between lactate levels and mortality, nor does it suggest a specific uniform treatment strategy for all patients with a given lactate level. Lactate levels rise in septic shock through multiple mechanisms. The diverse mechanisms range from hypoperfusion to potentially adaptive metabolic changes to impaired renal and hepatic clearance. 12 Hyperlactatemia is currently most useful as a global indicator of prognosis. A small number of patients died (the primary outcome), and the OR for death in patients with an elevated lactate level had a lower confidence limit approaching 1.00. Additional confounders could render the association insignificant, and unmeasured confounders may have accounted for the association found in this study. Pediatric sepsis studies are not always powered to detect mortality differences because mortality is rare. In addition to the association with mortality, this study also found that lactate levels were significantly associated with every prespecified clinical outcome. Despite the wide CI tempering the association with mortality, in the setting of literature demonstrating associations between lactate levels and mortality in ICU populations and the associations with secondary outcomes, this study may be interpreted as indicating that an initially elevated lactate level increased the risk for severe outcome in pediatric septic shock. This study, focused on diagnosis, represents a larger, more heterogeneous and less severely ill population than existing studies of pediatric sepsis, aligned with its primary aim. Richardson et al 32 recommend that studies of diagnostic tests evaluate a representative sample of patients presenting with a diagnostic dilemma. All patients raised enough clinical concern for potential severe sepsis to prompt physicians to test for elevated lactate levels. Only a portion of these patients went on to receive true severe sepsis treatment, indicating an appropriately heterogeneous spectrum. Studying a population with only pediatric severe sepsis would miss the most important diagnostic window for lactate testing: early measurement before organ dysfunction is apparent. 33 Our study reflects the pragmatic population identified through the implementation of guidelines in a real-world setting where physicians have been taught to suspect sepsis in children with "decreased mental status and perfusion." 16(p677) The median volume of intravenous fluid administered to the population in this study is lower than in prior studies that included only patients with severe sepsis and septic shock who that falls outside recommendations for severe sepsis, many of them did not have severe sepsis. Timeliness in our study is similar to that reported in observational sepsis studies. [35] [36] [37] Regression analysis showed that including variables to measure treatment delivered after lactate levels were tested decreased the association between lactate level and mortality (eTable 3 in the Supplement). Because the lactate levels were known to clinicians, the elevated lactate levels may have prompted changes in care that decreased the mortality risk, or that other clinical features evident to clinicians prompted risk-lowering care in patients with hyperlactatemia.
Other clinical signs and symptoms may indicate prognosis in pediatric sepsis; however, many findings traditionally recommended have poor interrater reliability and depend on a clinician's pediatric acumen. [38] [39] [40] Most children in the United States present to nonpediatric facilities for emergency care. Objective recognition strategies, such as measurement of lactate levels, that may be measured by any clinician and communicated and trended across care settings, have potential to be safer and more effective than skilldependent assessments.
Limitations
This study was subject to selection bias, depending on a lactate level measurement for inclusion. The decision to test lactate levels reflects a clinical assessment of pretest probability on the part of the physician, a key component to the use of a diagnostic test.
Whether its use in diagnostic testing would differentially affect the association between the exposure and outcome in the patients who do not undergo lactate level measurement remains unclear. The severity of illness in patients with unmeasured lactate levels was lower, suggesting that clinically meaningful discretion was exercised in the decision not to measure a lactate level. The study was subject to performance bias, in which clinicians might be expected to deliver better care to patients with elevated lactate levels. This expectation would bias the study toward the null hypothesis. As a single-center study, the findings may not be generalizable to other sites. This study was not designed to calculate an optimized cut point for lactate levels, but optimizing pediatric thresholds might be a useful future larger study.
Conclusions
This study establishes an association between early ED lactate levels and mortality in pediatric sepsis. In addition to prior pediatric work showing that early lactate levels are associated with organ dysfunction and that lactate levels are associated with mortality in the ICU, as well as the demonstrated effectiveness of lactate level measurement in adult sepsis care, this study suggests the possible utility of incorporating lactate level testing in the emergency care of pediatric sepsis. Further studies are needed to examine the effect of the implementation of lactate level testing on patient outcomes in pediatric sepsis. 
